MTaI discusses opportunities, challenges within MedTech domain
Several strategic discussions took place aiming to promote India as an attractive destination for investments from global as well as domestic players
The Medical Technology Association of India (MTaI) hosted a meeting with international delegates, government stakeholders, and MedTech industry captains in New Delhi. The event was graced by Aseem Sahu, Deputy Drugs Controller, CDSCO, and Abby Pratt, Senior Vice President, Advanced Medical Technology Association (AdvaMed).
The discussion revolved around opportunities and current challenges within the MedTech domain including tariff and non-tariff barriers, friend-shoring opportunities, and streamlining of the regulations. Several strategic discussions also took place aiming to promote India as an attractive destination for investments from global as well as domestic players. During the event, the Deputy Drugs Controller stated that quality and patient safety are at the centre of any policy or related decisions that the government makes and is already working towards global harmonisation of standards, capacity building, and promoting innovation in the MedTech space.
Pavan Choudary, Chairman, MTaI stated, “As we navigate the evolving landscape of MedTech in India, harmonising Indian regulations and standards with global best practices will be the keystone which will not only attract international investment in the sector but will also enable Indian manufacturers to get greater acceptability of their products in global markets, furthering the Make in India objective of the government and keeping India aligned to global supply chains. We feel that domestic and international currents will together help carve out key policy recommendations which will be instrumental in furthering the MedTech industry in India.”
“I would also like to thank CDSCO, AdvaMed, our member CEOs, GAs & RAs colleagues for their vital contribution in taking this dialogue further,” Choudary added.
Abby Pratt, Senior Vice President, AdvaMed stated, “I want to thank MTaI for the opportunity to participate in their fraternity meeting and for advancing the medical device industry’s agenda forward with the relevant government stakeholders. I appreciate for this vital dialogue on the importance of harmonised regulations and global consensus standards. It is also reassuring to see the inclusive approach of the government to consult with industry on policy matters and regulations and offer the association’s cooperation to the government. The government-industry discourse underscores India’s intent and its potential to emerge as a key player in the global MedTech arena. The commitment seen in these discussions demonstrates India’s vision towards creating a conducive ecosystem for medical technology.”
